v3.26.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Stock-Based Compensation  
Schedule of stock option activity and related information

  ​ ​ ​

Number of Shares

  ​ ​ ​

Weighted - Average Exercise Price

  ​ ​ ​

Weighted-Average Remaining Contractual Term (in years)

  ​ ​ ​

Aggregate Intrinsic Value
(in thousands)

Outstanding - December 31, 2025

10,675,615

$

13.46

8.60

$

243,979

Granted

371,400

$

22.68

Exercised

(25,767)

$

14.24

$

226

Forfeited or cancelled

(33,130)

$

13.24

Outstanding - March 31, 2026

10,988,118

$

13.77

8.40

$

68,892

Options vested and exercisable as of March 31, 2026

3,795,031

$

12.33

7.79

$

27,393

Options vested and expected to vest as of March 31, 2026

10,988,118

$

13.77

8.40

$

68,892

Summary of company's RSU activity

  ​ ​ ​

Number of Shares

  ​ ​ ​

Weighted - Average Grant Date Fair Value

Unvested as of December 31, 2025

599,675

$

14.23

Granted

87,075

$

25.41

Vested

$

Forfeited

(19,150)

$

12.10

Unvested as of March 31, 2026

667,600

$

15.75

Schedule of stock-based compensation expense as reflected in consolidated statements of operations

The Company recognized stock-based compensation expense related to the issuance of equity awards to employees and directors in the unaudited condensed consolidated statement of operations as follows (in thousands):

Three Months Ended March 31,

2026

2025

Research and development

$

3,096

$

1,581

General and administrative

6,099

3,805

Total stock-based compensation expense

$

9,195

$

5,386